Application of flow cytometry for biomarker-based cervical cancer cells detection

Diagnostic Cytopathology

Volumn 36, Issue 2, 2008, Pages 76-84

  Ling, Jian ^a   Wiederkehr, Urs ^b   Cabiness, Spring ^a   Shroyer, Kenneth R ^c   Robinson, J Paul ^d  

^a SOUTHWEST RESEARCH INSTITUTE   (United States)

^b Cytolution Inc   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Cancer markers; Cancer screening; Cervical cancer; Flow cytometry; Rare event detection

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MINICHROMOSOME MAINTENANCE PROTEIN 5;

ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTODIAGNOSIS; DISEASE MARKER; EPITHELIUM CELL; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

BIOPSY; CELL CYCLE PROTEINS; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FLOW CYTOMETRY; HELA CELLS; HUMANS; MASS SCREENING; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 38549167910     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20763     Document Type: Article

References (44)

1. Cancer Mondial 2000-2003, World Health Organization-International Agency for Research on Cancer. Available at http://www.dep.iarc.fr.
2. Cancer Facts and Figures 1997-2003, American Cancer Society. Available at http://www.cancer.org/docroot/STT/STT_0.asp.
3. DeMay RM. Practical principles of cytopathology. Chicago: American Society Clinical Pathology Press; 1999.
4. Cervical Cancer Home Page, National Cancer Institute. Available at http://www.cancer.gov/cancer_information/cancer_type/cervical/.
5. What tests are used to screen and diagnose cervical cancer. University of Maryland Medicine, 2004. Available at http://www.umm.edu/patiented/articles/ what_tests_used_screen_diagnose_cervical_cancer_000046_8.htm.
6. Cytyc Corporation 2002, Annual Report 2002. Available at http://ir.cytyc.com/downloads/cytc02.pdf.
7. Ducatman BS, Wang HH, The pap smear: Controversies in practice. London: Arnold Publisher; 2002.
8. Simon H, Cannistra SA. Cervical Cancer, A.D.A.M. Inc., 2003. Available at http://www.healthandage.com/html/well_connected/pdf/doc46.pdf.
9. Preventing and controlling cervical cancer in the new millennium. In: EUROGIN, Paris; 2003.
10. Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nat Rev Cancer 2003;3:217-226.
11. Santin AD, Zhan FH, Bignotti E, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: Identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005;331:269-291.
12. Davidson B, Goldberg I, Lerner-Geva L, et al. Expression of topoisomerase II and Ki-67 in cervical carcinoma - Clinicopathological study using immunohistochemistry. APMIS 2000;108:209.
13. Tae KY, Kyoung CE, Hoon CN, et al. Expression of cyclin E and p27(KIP1) in cervical carcinoma. Cancer Lett 2000;153:41-50.
14. Shroyer KR, Homer P, Heinz D, et al. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology. Cancer 2006;108:324-330.
15. von Knebel DM. Biomarkers in screening of cervical cancer. In: Monsonego J, editor. Emerging issues on HPV infections: From science to practice. Basel: Karger; 2006. p 1-19.
16. Bibbo M, Klump WJ, DeCecco J, et al. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol 2002;46:25-29.
17. Bibbo M, DeCecco J, Kovatich AJ. P16INK4A as an adjunct test in liquid-based cytology. Anal Quant Cytol Histol 2003;25:8-11.
18. Harris CP, Lu XY, Narayan G, et al. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 2003;36:233-241.
19. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
20. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399.
21. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and Thin-Prep smears. J Clin Pathol 2003;56:56-63.
22. Nuovo GJ, Plaia TW, Belinsky SA, et al. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999;96:12754-12759.
23. Park JS, Dong SM, Kim HS, et al. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett 1999;136:101-108.
24. Pientong C, Ekalaksananan T, Swadpanich U, et al. Immunocytochemical detection of p16INK4a protein in scraped cervical cells. Acta Cytol 2003;47:616-623.
25. Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol 2002;33:899-904.
26. Saqi A, Pasha TL, McGrath CM, et al. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 2002;27:365-370.
27. von Knebel Doeberitz M, New molecular tools for efficient screening of cervical cancer. Dis Markers 2001;17:123-128.
28. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-2242.
29. Laskey R. Initiation of DNA replication in normal and neoplastic cells. Presented at Fifth congress of the European haematology association, Birmingham, UK, 2000.
30. Williams GH, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 1998;95:14932-14937.
31. Tringler B, Gup CJ, Shroyer KR, Correlation between p16 and pRb expression in cervical squamous and glandular neoplasia. Human Pathol 2004;35:689-696.
32. Willman JH, Heinz D, Golitz LE, et al. Correlation of p16 and pRb expression with HPV detection in Bowen's disease. J Cutaneous Pathol 2006;33:629-633.
33. Nishiya I, Kikuchi T, Moriya S, et al. Cytophotometric study of premalignant and malignant cells of the cervix in an approach towards automated cytology. Acta Cytol 1977;21:271-275.
34. Watts KC, Husain OA, Campion MJ, et al. Quantitative DNA analysis of low grade cervical intraepithelial neoplasia and human papillomavirus infection by static and flow cytometry. Br Med J (Clin Res Ed). 1987;295:1090-1092.
35. Wheeless LL, Patten SF, Berkan TK, et al. Multidimensional slitscan prescreening system: Preliminary results of a single blind clinical study. Cytometry 1984;5:1-8.
36. Titley I, Tee DE, Driver M, et al., Can flow cytometry reduce the workload for cervical screening? The results of a series of 622 specimens. Cytopathology 1991;2:193-203.
37. Magtibay PM, Perrone JF, Stanhope CR, et al. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix. Gynecol Oncol 1999;75:20-24.
38. Bocking A, Motherby H, Assessment of cervical dysplasia with DNA image cytometry. Pathologe 1999;20:25-33.
39. van Leeuwen AM, Ploem-Zaaijer JJ, Pieters WJ, et al. The suitability of DNA cytometry for the prediction of the histological diagnosis in women with abnormal cervical smears. Br J Obstet Gynaecol 1996;103:359-365.
40. Kimmig R, Wimberger P, Kapsner T, et al. Flow cytometric DNA analysis using cytokeratin labeling for identification of tumor cells in carcinomas of the breast and the female genital tract. Anal Cell Pathol 2001;22:165-178.
41. Lin WM, Ashfaq R, Michalopulos EA, et al. Molecular Papanicolaou tests in the twenty-first century: Molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol 2000;183: 39-45.
42. Shapiro H. Beam geometry and pulse characteristics. In: Practical flow cytometry, 4th ed. New Jersey: Wiley; 2003. p 183-184.
43. Shapiro H. Intrinsic cellular parameters. In: Practical flow cytometry, 4th ed. New Jersey: Wiley; 2003. p 285-293.
44. Dong HP, Holth A, Berner A, Davidson B, Risberg B. Flow cytometric immunphenotyping of epithelial cancer cells in effusions - Technical considerations and pitfalls. Cytometry Part B 2007:72B: 332-343.